LRP5, SLC6A3, and SOX10 Expression in Conventional Ameloblastoma.
Lorena Correa-ArzateJavier Portilla-RobertsonJosué Orlando Ramírez-JarquínLuis Fernando Jacinto-AlemánClaudia Patricia Mejía-VelázquezFrancisco Germán Villanueva-SánchezMariana Rodríguez-VázquezPublished in: Genes (2023)
We identify LRP5, SLC6A3, and SOX10 as potentially important genes related to cell proliferation and invasion in the pathogenesis of ameloblastomas, along with both parthenolide and vorinostat as inhibitory drugs that could be further investigated for the development of novel therapeutic approaches against ameloblastoma.